European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 292-296 , September 2008

Abdominal Aortic Aneurysm and the Impact of Infectious Burden

  • A. Nyberg

      Affiliations

    • Department of Laboratory Medicine, Sundsvall County Hospital, Sundsvall, Sweden
  • ,
  • E. Skagius

      Affiliations

    • Department of Surgery, Sundsvall County Hospital, Sundsvall, Sweden
  • ,
  • E. Englund

      Affiliations

    • Research and Development Center, Sundsvall County Hospital, Sundsvall, Sweden
  • ,
  • I. Nilsson

      Affiliations

    • Department of Laboratory Medicine, Division of Medical Microbiology, University of Lund, Sweden
  • ,
  • Å. Ljungh

      Affiliations

    • Department of Laboratory Medicine, Division of Medical Microbiology, University of Lund, Sweden
  • ,
  • A.E. Henriksson

      Affiliations

    • Department of Surgery, Sundsvall County Hospital, Sundsvall, Sweden
    • Corresponding Author InformationCorresponding author. Anders Henriksson, MD, PhD, Department of Surgery, Sundsvall County Hospital, SE-851 86 Sundsvall, Sweden. Tel. +46 60 181430; fax: +46 60 181439.

Received 15 January 2008 ,Accepted 24 April 2008.

References 

  1. Choke E, Cockerill G, Wilson WRW, Sayed S, Dawson J, Loftus I, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. Eur J Vasc Endovasc Surg. 2005;30:227–244
  2. Karlsson L, Gnarpe J, Nääs J, Olsson G, Lindholm J, Steen B, et al. Detection of viable Chlamydia pneumoniae in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2000;19:630–635
  3. Karvonen M, Tuomilehto J, Pitkäniemi J, Naukkarinen A, Saikku P. Importance of smoking for Chlamydia pneumoniae seropositivity. Int J Epidemiol. 1994;23:1315–1321
  4. Cook PJ, Davies P, Wise R, Honeybourne D. Chlamydia pneumoniae infection and ethnic origin. Ethn Health. 1998;3:237–246
  5. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev. 2002;15:1–20
  6. Vammen S, Lindholt JS, Østergaard L, Fasting H, Henneberg EW. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg. 2001;88:1066–1072
  7. Mosorin M, Juvonen J, Biancari F, Satta J, Surcel HM, Leinonen M, et al. Use of doxycycline to decrease the growth rate of abdominal aortic aneurysms: a randomized, double-blind, placebo-controlled pilot study. J Vasc Surg. 2001;34:606–610
  8. Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437–439
  9. Ameriso SF, Fridman EA, Leiguarda RC, Sevlever GE. Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke. 2001;32:385–391
  10. Weel JFL, van der Hulst RWM, Gerrits Y, Roorda P, Feller M, Dankert J, et al. The interrelationship between cytotoxin-associated gene A, vacuolating cytotoxin, and Helicobacter pylori-related diseases. J Infect Dis. 1996;173:1171–1175
  11. Singh RK, McMahon AD, Patel H, Packard CJ, Rathbone BJ, Samani NJ. Prospective analysis of the association of infection with CagA bearing strains of Helicobacter pylori and coronary heart disease. Heart. 2002;88:43–46
  12. Mayr M, Kiechl S, Mendall MA, Willeit J, Wick G, Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains; prospective results from the Bruneck study. Stroke. 2003;34:610–615
  13. Danesh J, Collins R, Peto R. Chronic infections and coronary heart disease: is there a link?. Lancet. 1997;350:430–436
  14. Fabricant CG, Fabricant J, Litrenta MM, Minick CR. Virus-induced atherosclerosis. J Exp Med. 1978;148:335–340
  15. Degre´ M. Has cytomegalovirus infection any role in the development of atherosclerosis?. Clin Microbiol Infect. 2002;8:191–195
  16. Melnick JL, Hu C, Burek J, Adam E, DeBakey ME. Cytomegalovirus DNA in arterial wall of patients with atherosclerosis. J Med Virol. 1994;42:170–174
  17. Tanaka S, Komori K, Okadome K, Sugimachi K, Mori R. Detection of active cytomegalovirus infection in inflammatory aortic aneurysms with RNA polymerase chain reaction. J Vasc Surg. 1994;20:235–243
  18. Espinola-Klein C, Rupprecht HJ, Blankenberg S, Bickel C, Kopp H, Rippin G, et al. Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation. 2002;105:15–21
  19. MacSweeney STR, Powell JT, Greenhalg RM. Pathogenesis of abdominal aortic aneurysm. Br J Surg. 1994;81:935–941
  20. Grahame-Clarke C, Chan NN, Andrew D, Ridgway GL, Betteridge DJ, Emery V, et al. Human cytomegalovirus seropositivity is associated with impaired vascular function. Circulation. 2003;108:678–683
  21. Rothenbacher D, Brenner H, Hoffmeister A, Mertens T, Persson K, Koenig W. Relationship between infectious burden, systemic inflammatory response, and risk of stable coronary artery disease: role of confounding and reference group. Atherosclerosis. 2003;170:339–345
  22. Crawford ES. Ruptured aortic aneurysm. J Vasc Surg. 1991;13:348–350
  23. Grimes DA, Schulz KF. Compared to what? Finding controls for case-control studies. Lancet. 2005;365:1429–1433
  24. Sakalihasan N, Limet R, Defawe OD. Abdominal aortic aneurysm. Lancet. 2005;365:1577–1589
  25. Lelwala-Guruge J, Nilsson I, Ljungh Å, Wadström T. Cell surface proteins of Helicobacter pylori as antigens in an ELISA and a comparison with three commercial ELISA. Scand J Infect Dis. 1992;24:457–465
  26. Juvonen T, Biancari F, Juvonen J. Chlamydia pneumoniae and aortic aneurysms. Scand Cardiovasc J. 2002;36:327–328
  27. Ngeh J, Anand V, Gupta S. Chlamydia pneumoniae and atherosclerosis – what we know and what we don't. Clin Microbiol Infect. 2002;8:2–13
  28. Ieven MM, Hoymans VY. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence. J Clin Microbiol. 2005;43:19–24

PII: S1078-5884(08)00241-4

doi: 10.1016/j.ejvs.2008.04.017

European Journal of Vascular & Endovascular Surgery
Volume 36, Issue 3 , Pages 292-296 , September 2008